Raquel Jimenez (Raquel Jiménez-Segura)

Publication Activity (10 Years)

Years Active: 2019-2022
Publications (10 Years): 4

Top Topics

Multiple Myeloma

Acute Lymphoblastic Leukemia

Peritoneal Dialysis

Prognostic Factors

Top Venues

British journal of haematology

European journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

David F Moreno, Mónica López-Guerra, Sara Paz, Marta Garrote, Mari-Pau Mena, Juan G Correa, Anthony M Battram, Miguel Osuna, Alfredo Rivas-Delgado, Luis Gerardo Rodríguez-Lobato, Oriol Cardús, Natalia Tovar, María Teresa Cibeira, Raquel Jimenez, Joan Bladé, Laura Rosinol, Dolors Colomer, Carlos Fernández de Larrea
Prognostic impact of MYD88 and CXCR4 mutations assessed by droplet digital polymerase chain reaction in IgM monoclonal gammopathy of undetermined significance and smouldering Waldenström macroglobulinaemia. British journal of haematology (2022)
Luis-Gerardo Rodríguez-Lobato, Arturo Pereira, Carlos Fernández de Larrea, Maria Teresa Cibeira, Natalia Tovar, Raquel Jimenez, David F Moreno, Marta Garrote, Laura Rosinol, Joan Bladé
Real-world data on survival improvement in patients with multiple myeloma treated at a single institution over a 45-year period. British journal of haematology (2021)
Miquel Blasco, Alexandra Martínez-Roca, Luis G Rodríguez-Lobato, Adriana Garcia-Herrera, Laura Rosinol, Pedro Castro, Sara Fernández, Luis F Quintana, María T Cibeira, Joan Bladé, Carlos Fernández de Larrea, Natalia Tovar, Raquel Jimenez, Esteban Poch, Elena Guillen, Josep M Campistol, Enric Carreras, Maribel Díaz-Ricart, Marta Palomo
Complement as the enabler of carfilzomib-induced thrombotic microangiopathy. British journal of haematology 193 (1) (2020)
Raquel Jimenez, Miquel Granell, Mercè Gironella, Eugenia Abella, Antoni García-Guiñón, Albert Oriol, Elena Cabezudo, Victoria Clapés, Joan Alfons Soler, Lourdes Escoda, Jordi López-Pardo, Carlos Fernández de Larrea, Maria Teresa Cibeira, Natalia Tovar, Ignacio Isola, Joan Bladé, Laura Rosiñol, null null
Pomalidomide-dexamethasone for treatment of soft-tissue plasmacytomas in patients with relapsed / refractory multiple myeloma. European journal of haematology 102 (5) (2019)